{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:20:25Z","timestamp":1783948825316,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s13760-020-01521-0","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T17:04:56Z","timestamp":1602695096000},"page":"1783-1787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Botulinum toxin injection in the management of chronic migraine: the Saudi experience with a proposal for a new protocol"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9484-9838","authenticated-orcid":false,"given":"Hussein","family":"Algahtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Shirah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Sukkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatim","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem","family":"Meftah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Alhazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Alshareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmohsin","family":"Algethami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Alshanqiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Andeejani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"issue":"7","key":"1521_CR1","doi-asserted-by":"publisher","first-page":"e027953","DOI":"10.1136\/bmjopen-2018-027953","volume":"9","author":"CP Herd","year":"2019","unstructured":"Herd CP, Tomlinson CL, Rick C et al (2019) Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. BMJ Open 9(7):e027953","journal-title":"BMJ Open"},{"issue":"11","key":"1521_CR2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"LJ Stovner","year":"2018","unstructured":"Stovner LJ, Nichols E, Steiner TJ et al (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):954\u2013976","journal-title":"Lancet Neurol"},{"issue":"2","key":"1521_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553\u2013622","journal-title":"Physiol Rev"},{"issue":"8","key":"1521_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12(8):455\u2013464","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"1521_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/2040622315579627","volume":"6","author":"MW Weatherall","year":"2015","unstructured":"Weatherall MW (2015) The diagnosis and treatment of chronic migraine. Ther Adv Chronic Dis 6(3):115\u2013123","journal-title":"Ther Adv Chronic Dis"},{"issue":"8","key":"1521_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1212\/01.wnl.0000323925.29520.e7","volume":"71","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Reed M, Lipton RB (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71(8):559\u2013566","journal-title":"Neurology"},{"issue":"1","key":"1521_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s10194-019-1060-6","volume":"20","author":"E Kouremenos","year":"2019","unstructured":"Kouremenos E, Arvaniti C, Constantinidis TS et al (2019) Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine. J Headache Pain 20(1):113","journal-title":"J Headache Pain"},{"issue":"1","key":"1521_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s10194-019-1038-4","volume":"20","author":"EC Agostoni","year":"2019","unstructured":"Agostoni EC, Barbanti P, Calabresi P et al (2019) Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain 20(1):92","journal-title":"J Headache Pain"},{"issue":"3","key":"1521_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrneurol.2012.13","volume":"8","author":"HC Diener","year":"2012","unstructured":"Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD (2012) Chronic migraine\u2014classification, characteristics and treatment. Nat Rev Neurol 8(3):162\u2013171","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"1521_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/head.12774","volume":"56","author":"DW Dodick","year":"2016","unstructured":"Dodick DW, Loder EW, Manack Adams A et al (2016) Assessing barriers to chronic migraine consultation, diagnosis, and treatment: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache 56(5):821\u2013834","journal-title":"Headache"},{"key":"1521_CR11","first-page":"CD011616","volume":"6","author":"CP Herd","year":"2018","unstructured":"Herd CP, Tomlinson CL, Rick C et al (2018) Botulinum toxins for the prevention of migraine in adults. Cochrane Database Syst Rev 6:CD011616","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1521_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1177\/0333102410364676","volume":"30","author":"SK Aurora","year":"2010","unstructured":"Aurora SK, Dodick DW, Turkel CC et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30(7):793\u2013803","journal-title":"Cephalalgia"},{"issue":"7","key":"1521_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0333102410364677","volume":"30","author":"HC Diener","year":"2010","unstructured":"Diener HC, Dodick DW, Aurora SK et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30(7):804\u2013814","journal-title":"Cephalalgia"},{"issue":"8","key":"1521_CR14","first-page":"869","volume":"43","author":"Y Wu-fienberg","year":"2018","unstructured":"Wu-fienberg Y, Ansari H, Zardouz S et al (2018) Anatomical look into OnabotulinumtoxinA injection for chronic migraine headache. Reg Anesth Pain Med 43(8):869\u2013874","journal-title":"Reg Anesth Pain Med"},{"issue":"12","key":"1521_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1756285617731521","volume":"10","author":"CC Chiang","year":"2017","unstructured":"Chiang CC, Starling AJ (2017) OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience. Ther Adv Neurol Disord 10(12):397\u2013406","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"1521_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/ene.13523","volume":"25","author":"C Dom\u00ednguez","year":"2018","unstructured":"Dom\u00ednguez C, Pozo-rosich P, Torres-Ferr\u00fas M et al (2018) OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study. Eur J Neurol 25(2):411\u2013416","journal-title":"Eur J Neurol"},{"issue":"2","key":"1521_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/head.13713","volume":"60","author":"FA Khan","year":"2019","unstructured":"Khan FA, Mohammed AE, Poongkunran M, Chimakurthy A, Pepper M (2019) Wearing off effect of OnabotulinumtoxinA near the end of treatment cycle for chronic migraine: a 4-year clinical experience. Headache 60(2):430\u2013440","journal-title":"Headache"},{"issue":"4","key":"1521_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/WNF.0b013e3181914d0a","volume":"32","author":"O Lange","year":"2009","unstructured":"Lange O, Bigalke H, Dengler R, Wegner F, Degroot M, Wohlfarth K (2009) Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? Clin Neuropharmacol 32(4):213\u2013218","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"1521_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40265-018-0906-6","volume":"78","author":"JE Frampton","year":"2018","unstructured":"Frampton JE, Silberstein S (2018) Correction to: OnabotulinumtoxinA: a review in the prevention of chronic migraine. Drugs 78(6):715","journal-title":"Drugs"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01521-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T16:36:30Z","timestamp":1636734990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01521-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01521-0","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"23 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}